These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 27072327)

  • 21. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.
    Ho J; Reimer RA; Doulla M; Huang C
    Trials; 2016 Jul; 17(1):347. PubMed ID: 27456494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes, obesity and gut microbiota.
    Everard A; Cani PD
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):73-83. PubMed ID: 23768554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prebiotics and the Human Gut Microbiota: From Breakdown Mechanisms to the Impact on Metabolic Health.
    Bedu-Ferrari C; Biscarrat P; Langella P; Cherbuy C
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inulin-type fructans and whey protein both modulate appetite but only fructans alter gut microbiota in adults with overweight/obesity: A randomized controlled trial.
    Reimer RA; Willis HJ; Tunnicliffe JM; Park H; Madsen KL; Soto-Vaca A
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28730743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics, prebiotics and amelioration of diseases.
    Tsai YL; Lin TL; Chang CJ; Wu TR; Lai WF; Lu CC; Lai HC
    J Biomed Sci; 2019 Jan; 26(1):3. PubMed ID: 30609922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prebiotics and Probiotics in Digestive Health.
    Quigley EMM
    Clin Gastroenterol Hepatol; 2019 Jan; 17(2):333-344. PubMed ID: 30267869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota.
    Megur A; Daliri EB; Baltriukienė D; Burokas A
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiological role of host microbiota in the development of obesity.
    Kobyliak N; Virchenko O; Falalyeyeva T
    Nutr J; 2016 Apr; 15():43. PubMed ID: 27105827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of the Gut Microbiota in Childhood Obesity.
    Pihl AF; Fonvig CE; Stjernholm T; Hansen T; Pedersen O; Holm JC
    Child Obes; 2016 Aug; 12(4):292-9. PubMed ID: 27058515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiome approaches to treat obesity in humans.
    Bianchi F; Duque ALRF; Saad SMI; Sivieri K
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional interest of dietary fiber and prebiotics in obesity: Lessons from the MyNewGut consortium.
    Delzenne NM; Olivares M; Neyrinck AM; Beaumont M; Kjølbæk L; Larsen TM; Benítez-Páez A; Romaní-Pérez M; Garcia-Campayo V; Bosscher D; Sanz Y; van der Kamp JW
    Clin Nutr; 2020 Feb; 39(2):414-424. PubMed ID: 30904186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease.
    Esgalhado M; Kemp JA; Damasceno NR; Fouque D; Mafra D
    Future Microbiol; 2017 Nov; 12():1413-1425. PubMed ID: 29027814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Gut Microbiota, Probiotics and Prebiotics in the Cardiovascular Diseases.
    Oniszczuk A; Oniszczuk T; Gancarz M; Szymańska J
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33671813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
    Healey GR; Celiberto LS; Lee SM; Jacobson K
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prebiotics Inhibit Proteolysis by Gut Bacteria in a Host Diet-Dependent Manner: a Three-Stage Continuous
    Wang X; Gibson GR; Sailer M; Theis S; Rastall RA
    Appl Environ Microbiol; 2020 May; 86(10):. PubMed ID: 32198169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward a Personalized Approach in Prebiotics Research.
    Dey M
    Nutrients; 2017 Jan; 9(2):. PubMed ID: 28134778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.